Precision Neurology Blood Test
Neurodegenerative Disease Stratification
Research Use Only (RUO)Active
Key Facts
Indication
Neurodegenerative Disease Stratification
Phase
Research Use Only (RUO)
Status
Active
Company
About FBB Biomed
FBB Biomed is pioneering an AI-driven genomic health platform centered on the detection of Endogenous Ancestral Nucleotide Sequences (EANS) from blood. The company is transitioning from research to commercial activity, having recently signed an agreement with a CLIA/CAP-certified lab to offer its first Research Use Only (RUO) test for neurology. Led by a seasoned CEO with a history of diagnostic innovation, FBB aims to revolutionize disease monitoring and patient stratification, starting with neurodegenerative conditions like multiple sclerosis and Parkinson's disease.
View full company profile